Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Index- P/E- EPS (ttm)-0.42 Insider Own0.01% Shs Outstand1.12B Perf Week-1.04%
Market Cap18.73B Forward P/E6.18 EPS next Y2.70 Insider Trans-86.54% Shs Float1.12B Perf Month29.90%
Income-461.00M PEG- EPS next Q0.60 Inst Own53.51% Short Float1.09% Perf Quarter27.81%
Sales16.02B P/S1.17 EPS this Y-4.95% Inst Trans8.96% Short Ratio1.20 Perf Half Y90.70%
Book/sh6.43 P/B2.60 EPS next Y11.13% ROA-1.07% Short Interest12.22M Perf Year102.24%
Cash/sh2.67 P/C6.26 EPS next 5Y1.60% ROE-6.08% 52W Range7.09 - 17.13 Perf YTD60.01%
Dividend Est.- P/FCF8.05 EPS past 5Y26.63% ROI-1.91% 52W High-2.48% Beta0.90
Dividend TTM- Quick Ratio0.61 Sales past 5Y-2.68% Gross Margin49.00% 52W Low135.78% ATR (14)0.50
Dividend Ex-DateNov 27, 2017 Current Ratio0.89 EPS Y/Y TTM71.44% Oper. Margin20.90% RSI (14)71.92 Volatility3.07% 3.28%
Employees37226 Debt/Eq2.74 Sales Y/Y TTM7.21% Profit Margin-2.88% Recom2.08 Target Price18.00
Option/ShortYes / Yes LT Debt/Eq2.32 EPS Q/Q32.68% Payout- Rel Volume0.68 Prev Close16.29
Sales Surprise2.34% EPS Surprise-6.58% Sales Q/Q4.84% EarningsMay 08 BMO Avg Volume10.15M Price16.70
SMA2013.07% SMA5018.40% SMA20047.68% Trades Volume2,796,266 Change2.55%
Date Action Analyst Rating Change Price Target Change
Mar-08-24Upgrade JP Morgan Underweight → Neutral $14
Feb-12-24Upgrade Piper Sandler Neutral → Overweight $12 → $19
Jan-23-24Upgrade Jefferies Hold → Buy $10 → $14
Jan-03-24Upgrade Piper Sandler Underweight → Neutral $8 → $12
Dec-18-23Initiated HSBC Securities Buy $13
Nov-27-23Upgrade UBS Neutral → Buy $11 → $13
Jul-06-23Upgrade UBS Sell → Neutral $7 → $8
May-25-23Initiated Morgan Stanley Equal-Weight $10
May-18-23Upgrade Evercore ISI In-line → Outperform
Jan-19-23Downgrade Jefferies Buy → Hold $10 → $12
May-17-24 11:00AM
09:06AM
May-16-24 06:15AM
May-15-24 09:12AM
08:15AM
07:00AM Loading…
May-14-24 07:00AM
May-13-24 09:40AM
09:40AM
May-09-24 11:37AM
09:33AM
06:22AM
May-08-24 04:29PM
04:02PM
02:10PM
02:00PM
12:51PM Loading…
12:51PM
11:56AM
10:47AM
09:42AM
09:30AM
09:18AM
08:53AM
08:53AM
07:58AM
07:55AM
07:28AM
07:20AM
07:19AM
07:00AM
06:56AM
06:36AM Loading…
06:36AM
06:30AM
May-07-24 04:30PM
12:45PM
May-03-24 05:58PM
09:15AM
May-02-24 06:30PM
10:48AM
08:30AM
08:01AM
03:41AM
Apr-30-24 11:32AM
04:00AM
Apr-22-24 11:37AM
Apr-21-24 10:39AM
Apr-16-24 05:43PM
08:00AM
Apr-15-24 05:21PM
Apr-11-24 08:30AM
Apr-09-24 04:30PM
Apr-06-24 01:00PM
Apr-04-24 08:30AM
Apr-03-24 05:21AM
05:00AM
Apr-01-24 02:01PM
11:52AM
08:30AM
Mar-24-24 07:30PM
Mar-21-24 11:10PM
Mar-18-24 03:06PM
Mar-08-24 05:00AM
Feb-26-24 02:19PM
09:58AM
07:00AM
Feb-23-24 08:15PM
Feb-20-24 08:30AM
04:43AM
04:00AM
Feb-16-24 09:04AM
08:57AM
Feb-13-24 12:08AM
Feb-12-24 10:18AM
Feb-09-24 05:02PM
Feb-05-24 09:02AM
Feb-01-24 11:42AM
Jan-31-24 04:05PM
03:51PM
02:55PM
01:30PM
01:07PM
10:30AM
10:20AM
09:09AM
08:10AM
07:52AM
07:20AM
07:00AM
06:32AM
06:20AM
06:00AM
Jan-28-24 12:42PM
Jan-26-24 09:15AM
Jan-25-24 09:40AM
Jan-23-24 01:43AM
Jan-12-24 09:00AM
Jan-10-24 05:21AM
Jan-02-24 04:30PM
Dec-29-23 06:43PM
06:34PM
06:14PM
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weiss AmirChief Accounting OfficerMay 16 '24Sale16.6512,635210,3775,179May 17 07:41 AM
Weiss AmirChief Accounting OfficerMay 15 '24Sale16.8015,500260,41717,814May 17 07:41 AM
Conway Vikki LSee "Remarks"May 13 '24Sale16.7415,219254,8070May 15 08:36 AM
Kalif Eliyahu SharonEVP, Chief Financial OfficerMar 06 '24Sale13.5277,5501,048,119203,691Mar 07 04:27 PM
Sabag MarkEVP, International MarketsMar 05 '24Sale13.52100,0001,352,090382,590Mar 07 04:12 PM
Daniell RichardExec. VP, European CommercialMar 05 '24Sale13.5248,629657,24069,770Mar 07 04:20 PM
Conway Vikki LSee "Remarks"Mar 05 '24Sale13.521,42719,28615,219Mar 07 04:16 PM
Daniell RichardExec. VP, European CommercialMar 04 '24Sale13.3495,7621,277,20769,770Mar 05 04:21 PM
Francis Richard DPresident and CEOMar 04 '24Sale13.3431,061414,270123,295Mar 05 04:27 PM
Hughes Eric ASee "Remarks"Mar 04 '24Sale13.348,045107,29916,855Mar 05 04:16 PM
Conway Vikki LSee "Remarks"Mar 04 '24Sale13.373,53247,2346,617Mar 05 04:39 PM
Daniell RichardExec. VP, European CommercialFeb 28 '24Sale13.1220,599270,17669,770Mar 01 06:43 AM
Drape EricExecutive VP Global OperationsFeb 28 '24Sale13.129,815128,7349,701Mar 01 06:45 AM
Conway Vikki LSee "Remarks"Feb 28 '24Sale13.121,36617,9162,928Mar 01 06:40 AM
Drape EricExecutive VP Global OperationsFeb 16 '24Sale13.05173,2612,261,9051Feb 21 07:37 AM
Francis Richard DPresident and CEOFeb 15 '24Sale13.1574,530980,17487,125Feb 20 07:42 AM
Weiss AmirChief Accounting OfficerFeb 01 '24Sale12.3731,766392,95510,676Feb 05 07:49 AM
Kalif Eliyahu SharonEVP, Chief Financial OfficerAug 07 '23Sale9.7335,125341,88999,162Aug 09 04:02 PM
Weiss AmirChief Accounting OfficerAug 04 '23Sale9.921,98119,65842,442Aug 07 04:15 PM
Hughes Eric ASee "Remarks"Aug 01 '23Sale8.3052,742437,6900Aug 03 07:09 AM